FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved an original ANDA for lisdexamfetamine dimesylate (Novadoz Pharmaceuticals LLC), a generic version of the stimulant used to treat attention-deficit/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Binge Eating Disorder

Drugs mentioned

• LISDEXAMFETAMINE DIMESYLATE (Lisdexamfetamine dimesylate)

Snippet

ORIG AP for LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)